KaliVir Immunotherapeutics
Tullia Bruno is on the Board of Advisors at KaliVir Immunotherapeutics. Tullia is also the Assistant Professor at University of Pittsburgh.
This person is not in the org chart
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells